is a senior bioanalytical expert specializing in regulated ligand binding (LBA), biomarker and immunogenicity (ADA) assay development and validation. With 7+ years in a multinational biopharmaceutical company and over a decade of research at the Max Planck Institute, she has led GLP and GCLP sample analytics for pre‑clinical and clinical studies, supported audits and regulatory inspections, and published in high‑impact journals.